As of 2025-08-15, the Relative Valuation of Novocure Ltd (NVCR) is (74.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.59 USD, the upside of Novocure Ltd based on Relative Valuation is -746.8%.
The range of the Relative Valuation is (64.28) - (86.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 42.0x - 56.6x | 49.5x |
| Forward P/E multiples | 41.0x - 57.2x | 48.6x |
| Fair Price | (64.28) - (86.48) | (74.96) |
| Upside | -654.6% - -846.2% | -746.8% |
| Date | P/E |
| 2025-08-12 | -7.42 |
| 2025-08-11 | -7.13 |
| 2025-08-08 | -7.28 |
| 2025-08-07 | -7.53 |
| 2025-08-06 | -7.45 |
| 2025-08-05 | -7.48 |
| 2025-08-04 | -7.69 |
| 2025-08-01 | -7.40 |
| 2025-07-31 | -7.57 |
| 2025-07-30 | -7.17 |
| 2025-07-29 | -7.44 |
| 2025-07-28 | -7.61 |
| 2025-07-25 | -7.87 |
| 2025-07-24 | -8.20 |
| 2025-07-23 | -10.80 |
| 2025-07-22 | -10.66 |
| 2025-07-21 | -10.53 |
| 2025-07-18 | -10.48 |
| 2025-07-17 | -10.60 |
| 2025-07-16 | -10.85 |
| 2025-07-15 | -10.98 |
| 2025-07-14 | -11.39 |
| 2025-07-11 | -11.51 |
| 2025-07-10 | -12.07 |
| 2025-07-09 | -11.90 |
| 2025-07-08 | -11.45 |
| 2025-07-07 | -11.05 |
| 2025-07-03 | -11.58 |
| 2025-07-02 | -11.69 |
| 2025-07-01 | -11.69 |
| 2025-06-30 | -11.64 |
| 2025-06-27 | -11.77 |
| 2025-06-26 | -11.18 |
| 2025-06-25 | -11.33 |
| 2025-06-24 | -11.12 |
| 2025-06-23 | -10.86 |
| 2025-06-20 | -10.92 |
| 2025-06-18 | -10.99 |
| 2025-06-17 | -11.40 |
| 2025-06-16 | -11.71 |
| 2025-06-13 | -11.48 |
| 2025-06-12 | -11.90 |
| 2025-06-11 | -11.35 |
| 2025-06-10 | -12.02 |
| 2025-06-09 | -11.05 |
| 2025-06-06 | -11.12 |
| 2025-06-05 | -10.76 |
| 2025-06-04 | -10.93 |
| 2025-06-03 | -11.14 |
| 2025-06-02 | -11.14 |